Literature DB >> 18346232

Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A.

Luca Padua1, Michael E Shy, Irene Aprile, Tiziana Cavallaro, Davide Pareyson, Aldo Quattrone, Nicolo Rizzuto, Giuseppe Vita, Pietro Tonali, Angelo Schenone.   

Abstract

Quality of life (QoL), as defined by the Short Form 36, has previously been shown to be abnormal in patients with Charcot-Marie-Tooth disease (CMT), both for Physical Composite Scores (PCS) and Mental Composite Scores (MCS). We have now extended these observations in a multicenter evaluation of 89 patients with Charcot-Marie-Tooth disease type 1A, the most common form of CMT. Both the PCS and MCS were abnormal also in this cohort, compared with the Italian population at large. In particular, the ability to ambulate independently as well as toe and heel walk correlated well with QoL measures in our patients.

Entities:  

Mesh:

Year:  2008        PMID: 18346232     DOI: 10.1111/j.1529-8027.2008.00159.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  11 in total

Review 1.  Quality of life in rare genetic conditions: a systematic review of the literature.

Authors:  Julie S Cohen; Barbara B Biesecker
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

2.  Small nerve fiber involvement in CMT1A.

Authors:  Maria Nolano; Fiore Manganelli; Vincenzo Provitera; Chiara Pisciotta; Annamaria Stancanelli; Giuseppe Caporaso; Rosa Iodice; Michael E Shy; Lucio Santoro
Journal:  Neurology       Date:  2014-12-24       Impact factor: 9.910

3.  Quality-of-life in Charcot-Marie-Tooth disease: the patient's perspective.

Authors:  Nicholas E Johnson; Chad R Heatwole; Nuran Dilek; Janet Sowden; Callyn A Kirk; Denise Shereff; Michael E Shy; David N Herrmann
Journal:  Neuromuscul Disord       Date:  2014-06-27       Impact factor: 4.296

4.  Patient identification of the symptomatic impact of charcot-marie-tooth disease type 1A.

Authors:  Nicholas E Johnson; Chad R Heatwole; Michele Ferguson; Janet E Sowden; Shanie Jeanat; David N Herrmann
Journal:  J Clin Neuromuscul Dis       Date:  2013-09

5.  The Charcot-Marie-Tooth Health Index: Evaluation of a Patient-Reported Outcome.

Authors:  Nicholas E Johnson; Chad Heatwole; Peter Creigh; Michael P McDermott; Nuran Dilek; Man Hung; Jerry Bounsanga; Wan Tang; Michael E Shy; David N Herrmann
Journal:  Ann Neurol       Date:  2018-08-29       Impact factor: 10.422

Review 6.  Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review.

Authors:  Joana L C Cordeiro; Wilson Marques; Jaime E C Hallak; Flávia L Osório
Journal:  ASN Neuro       Date:  2014-05-27       Impact factor: 4.146

7.  Quality of life in polyneuropathy: association with biomarkers of small fiber impairment.

Authors:  Meng-Ting Lin; Lukas Jyuhn-Hsiarn Lee; Chi-Chao Chao; Sung-Tsang Hsieh
Journal:  Health Qual Life Outcomes       Date:  2015-10-15       Impact factor: 3.186

8.  Gender Differences in Non-sex Linked Disorders: Insights From Huntington's Disease.

Authors:  Daniel Zielonka; Barbara Stawinska-Witoszynska
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

9.  Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey.

Authors:  Matthias Boentert; Rainer Dziewas; Anna Heidbreder; Svenja Happe; Ilka Kleffner; Stefan Evers; Peter Young
Journal:  J Neurol       Date:  2009-11-24       Impact factor: 4.849

10.  Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer.

Authors:  Giuseppe Vita; Stefania La Foresta; Massimo Russo; Gian Luca Vita; Sonia Messina; Christian Lunetta; Anna Mazzeo
Journal:  Neuromuscul Disord       Date:  2016-06-07       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.